HK Stock MarketDetailed Quotes

01558 HEC CJ PHARM

Watchlist

9.330
+0.230+2.53%

Not Open Oct 4 16:08 CST

8.21BMarket Cap4.55P/E (TTM)

HEC CJ PHARM Key Stats

Cash Flow

All

YOY

Hide blank lines

(Q6)Jun 30, 2024

(FY)Dec 31, 2023

(Q6)Jun 30, 2023

(FY)Dec 31, 2022

(Q6)Jun 30, 2022

(FY)Dec 31, 2021

(Q9)Sep 30, 2021

(Q6)Jun 30, 2021

(Q3)Mar 31, 2021

(FY)Dec 31, 2020

Assets

Current assets

Inventory

64.38%581.15M

29.85%409.05M

12.12%353.55M

12.63%315.03M

-19.58%315.32M

-26.06%279.7M

----

21.56%392.08M

----

96.69%378.27M

Accounts receivable

73.41%1.99B

103.76%2.11B

42.16%1.15B

89.64%1.04B

105.56%805.73M

-8.83%546.79M

----

-62.28%391.98M

----

-74.58%599.76M

Advance deposits and other receivables

468.61%391.57M

355.65%270.81M

-8.18%68.87M

664.31%59.43M

156.98%75M

-60.98%7.78M

----

--29.18M

----

--19.93M

Cash and equivalents

-59.72%1.52B

81.30%1.67B

340.18%3.78B

-18.35%923.54M

-35.29%859.1M

-44.69%1.13B

----

-60.32%1.33B

----

-26.42%2.04B

Secured deposit

-21.84%973.43M

1,941.26%1.57B

752.15%1.25B

-16.54%76.78M

8.89%146.14M

-58.41%91.99M

----

--134.21M

----

--221.19M

Financial assets at fair value-current assets

-30.26%13.33M

-93.56%18.69M

--19.12M

--290M

----

Special items of current assets

----

--2.31B

----

Total current assets

-17.31%5.47B

20.72%6.05B

200.46%6.61B

143.71%5.01B

-3.24%2.2B

-36.97%2.06B

----

-51.67%2.28B

----

-38.77%3.26B

Non-current assets

Fixed assets

-0.05%3.56B

----

9.66%3.56B

----

7.76%3.25B

13.43%3.22B

----

40.49%3.01B

----

40.00%2.84B

Property, plant and equipment

----

7.22%3.4B

----

--3.17B

----

Advance payment

45.80%323.21M

-60.99%115.38M

17.15%221.69M

356.24%295.76M

-46.83%189.24M

-89.80%64.83M

----

-75.32%355.89M

----

-59.17%635.32M

Associated company interest

--12.41M

--12.57M

----

Financial assets at fair value-non-current assets

7.01%13.21M

--19.59M

-99.31%12.35M

----

--1.79B

----

Intangible assets

-0.08%2.91B

-11.07%2.91B

-9.00%2.92B

-0.07%3.27B

4.43%3.2B

20.76%3.27B

----

85.21%3.07B

----

227.13%2.71B

Goodwill

----

0.00%75.9M

----

0.00%75.9M

----

0.00%75.9M

Deferred tax assets

70.40%204.59M

69.04%237.69M

12.58%120.07M

115.27%140.61M

-14.96%106.65M

60.70%65.32M

----

-3.98%125.42M

----

-57.56%40.65M

Total non-current assets

2.86%7.03B

-2.68%6.69B

-20.69%6.83B

-18.96%6.88B

29.73%8.61B

34.73%8.48B

----

15.41%6.64B

----

37.44%6.3B

Total assets

-7.07%12.49B

7.19%12.74B

24.33%13.44B

12.79%11.89B

21.32%10.81B

10.25%10.54B

--10.07B

-14.78%8.91B

--8.91B

-3.54%9.56B

Liabilities

Current liabilities

Accounts payable

-17.43%1.25B

2.16%1.76B

50.47%1.51B

88.47%1.72B

-4.51%1B

-27.61%911.68M

----

-47.00%1.05B

----

-33.30%1.26B

Tax payable

-98.97%1.28M

1,585.99%146.21M

--124.42M

-95.63%8.67M

----

871.84%198.63M

----

-86.82%20.44M

Bank loans and overdrafts

-69.03%1.23B

-25.90%2.32B

37.21%3.97B

6,357.30%3.13B

22,043.85%2.9B

-98.28%48.48M

----

-96.34%13.08M

----

2,026.34%2.82B

Financial lease liabilities-current liabilities

--3.36M

--359K

----

Deferred income-current liabilities

0.00%8.2M

3.81%8.2M

87.14%8.2M

-2.96%7.89M

0.00%4.38M

----

85.77%8.14M

----

0.00%4.38M

Total current liabilities

-55.13%2.54B

-12.32%4.33B

42.40%5.66B

299.07%4.94B

259.65%3.97B

-70.25%1.24B

----

-54.59%1.1B

----

80.01%4.16B

Net current assets

206.49%2.93B

2,249.62%1.72B

153.96%956.11M

-91.06%73.24M

-251.41%-1.77B

191.33%819.31M

----

-48.55%1.17B

----

-129.71%-897.1M

Total assets less current liabilities

27.86%9.96B

21.05%8.41B

13.83%7.79B

-25.31%6.95B

-12.40%6.84B

72.29%9.3B

--10.07B

-2.72%7.81B

--8.91B

-28.95%5.4B

Non-current liabilities

Long-term bank loan

115.67%1.09B

-58.31%288.29M

-23.39%507.08M

-78.01%691.53M

-78.46%661.91M

1,556.56%3.15B

----

4.14%3.07B

----

-93.46%189.85M

Financial lease liabilities-non-current liabilities

--12.16M

--1.17M

----

Deferred income-non-current liabilities

-0.46%184.55M

-0.18%187.15M

-2.53%185.39M

36.13%187.49M

36.21%190.21M

29.27%137.73M

----

35.92%139.65M

----

42.18%106.54M

Total non-current liabilities

86.34%1.29B

-45.78%476.6M

-18.73%692.48M

-73.22%879.02M

-73.47%852.12M

1,007.56%3.28B

----

5.21%3.21B

----

-90.05%296.4M

Total liabilities

-39.71%3.83B

-17.37%4.81B

31.60%6.35B

28.73%5.82B

11.78%4.83B

1.42%4.52B

----

-21.31%4.32B

----

-15.72%4.46B

Total assets less total liabilities

22.15%8.67B

30.73%7.94B

18.46%7.09B

0.82%6.07B

30.27%5.99B

17.97%6.02B

----

-7.58%4.6B

----

10.39%5.1B

Total equity and non-current liabilities

27.86%9.96B

21.05%8.41B

13.83%7.79B

-25.31%6.95B

-12.40%6.84B

72.29%9.3B

----

-2.72%7.81B

----

-28.95%5.4B

Equity

Share capital

0.00%879.97M

----

0.00%879.97M

----

96.06%879.97M

Reserve

29.02%7.79B

40.97%7.06B

23.26%6.03B

1.55%5B

39.71%4.9B

22.87%4.93B

----

-9.69%3.5B

----

-2.21%4.01B

Shareholders' Equity

25.32%8.67B

34.85%7.94B

19.72%6.91B

1.32%5.88B

31.74%5.78B

18.75%5.81B

----

-7.90%4.38B

----

10.95%4.89B

Non-controlling interest

----

-15.63%179.55M

-12.88%185.12M

0.10%212.82M

-0.04%212.48M

----

-0.57%212.61M

----

-0.95%212.56M

Total equity

22.15%8.67B

30.73%7.94B

18.46%7.09B

0.82%6.07B

30.27%5.99B

17.97%6.02B

----

-7.58%4.6B

----

10.39%5.1B

Total equity and total liabilities

-7.07%12.49B

7.19%12.74B

24.33%13.44B

12.79%11.89B

21.32%10.81B

10.25%10.54B

--10.07B

-14.78%8.91B

--8.91B

-3.54%9.56B

Currency Unit

CNY

Accounting Standards

IAS

CAS (2007)

IAS

CAS (2007)

IAS

Audit Opinions

Unqualified Opinion

Auditor

KPMG Huazhen Certified Public Accountants (Special General Partnership)

	(Q6)Jun 30, 2024	(FY)Dec 31, 2023	(Q6)Jun 30, 2023	(FY)Dec 31, 2022	(Q6)Jun 30, 2022	(FY)Dec 31, 2021	(Q9)Sep 30, 2021	(Q6)Jun 30, 2021	(Q3)Mar 31, 2021	(FY)Dec 31, 2020
Assets
Current assets
Inventory	64.38%581.15M	29.85%409.05M	12.12%353.55M	12.63%315.03M	-19.58%315.32M	-26.06%279.7M	----	21.56%392.08M	----	96.69%378.27M
Accounts receivable	73.41%1.99B	103.76%2.11B	42.16%1.15B	89.64%1.04B	105.56%805.73M	-8.83%546.79M	----	-62.28%391.98M	----	-74.58%599.76M
Advance deposits and other receivables	468.61%391.57M	355.65%270.81M	-8.18%68.87M	664.31%59.43M	156.98%75M	-60.98%7.78M	----	--29.18M	----	--19.93M
Cash and equivalents	-59.72%1.52B	81.30%1.67B	340.18%3.78B	-18.35%923.54M	-35.29%859.1M	-44.69%1.13B	----	-60.32%1.33B	----	-26.42%2.04B
Secured deposit	-21.84%973.43M	1,941.26%1.57B	752.15%1.25B	-16.54%76.78M	8.89%146.14M	-58.41%91.99M	----	--134.21M	----	--221.19M
Financial assets at fair value-current assets	-30.26%13.33M	-93.56%18.69M	--19.12M	--290M	----	----	----	----	----	----
Special items of current assets	----	----	----	--2.31B	----	----	----	----	----	----
Total current assets	-17.31%5.47B	20.72%6.05B	200.46%6.61B	143.71%5.01B	-3.24%2.2B	-36.97%2.06B	----	-51.67%2.28B	----	-38.77%3.26B
Non-current assets
Fixed assets	-0.05%3.56B	----	9.66%3.56B	----	7.76%3.25B	13.43%3.22B	----	40.49%3.01B	----	40.00%2.84B
Property, plant and equipment	----	7.22%3.4B	----	--3.17B	----	----	----	----	----	----
Advance payment	45.80%323.21M	-60.99%115.38M	17.15%221.69M	356.24%295.76M	-46.83%189.24M	-89.80%64.83M	----	-75.32%355.89M	----	-59.17%635.32M
Associated company interest	--12.41M	--12.57M	----	----	----	----	----	----	----	----
Financial assets at fair value-non-current assets	7.01%13.21M	--19.59M	-99.31%12.35M	----	--1.79B	--1.79B	----	----	----	----
Intangible assets	-0.08%2.91B	-11.07%2.91B	-9.00%2.92B	-0.07%3.27B	4.43%3.2B	20.76%3.27B	----	85.21%3.07B	----	227.13%2.71B
Goodwill	----	----	----	----	0.00%75.9M	0.00%75.9M	----	0.00%75.9M	----	0.00%75.9M
Deferred tax assets	70.40%204.59M	69.04%237.69M	12.58%120.07M	115.27%140.61M	-14.96%106.65M	60.70%65.32M	----	-3.98%125.42M	----	-57.56%40.65M
Total non-current assets	2.86%7.03B	-2.68%6.69B	-20.69%6.83B	-18.96%6.88B	29.73%8.61B	34.73%8.48B	----	15.41%6.64B	----	37.44%6.3B
Total assets	-7.07%12.49B	7.19%12.74B	24.33%13.44B	12.79%11.89B	21.32%10.81B	10.25%10.54B	--10.07B	-14.78%8.91B	--8.91B	-3.54%9.56B
Liabilities
Current liabilities
Accounts payable	-17.43%1.25B	2.16%1.76B	50.47%1.51B	88.47%1.72B	-4.51%1B	-27.61%911.68M	----	-47.00%1.05B	----	-33.30%1.26B
Tax payable	-98.97%1.28M	1,585.99%146.21M	--124.42M	-95.63%8.67M	----	871.84%198.63M	----	----	----	-86.82%20.44M
Bank loans and overdrafts	-69.03%1.23B	-25.90%2.32B	37.21%3.97B	6,357.30%3.13B	22,043.85%2.9B	-98.28%48.48M	----	-96.34%13.08M	----	2,026.34%2.82B
Financial lease liabilities-current liabilities	--3.36M	--359K	----	----	----	----	----	----	----	----
Deferred income-current liabilities	0.00%8.2M	0.00%8.2M	3.81%8.2M	87.14%8.2M	-2.96%7.89M	0.00%4.38M	----	85.77%8.14M	----	0.00%4.38M
Total current liabilities	-55.13%2.54B	-12.32%4.33B	42.40%5.66B	299.07%4.94B	259.65%3.97B	-70.25%1.24B	----	-54.59%1.1B	----	80.01%4.16B
Net current assets	206.49%2.93B	2,249.62%1.72B	153.96%956.11M	-91.06%73.24M	-251.41%-1.77B	191.33%819.31M	----	-48.55%1.17B	----	-129.71%-897.1M
Total assets less current liabilities	27.86%9.96B	21.05%8.41B	13.83%7.79B	-25.31%6.95B	-12.40%6.84B	72.29%9.3B	--10.07B	-2.72%7.81B	--8.91B	-28.95%5.4B
Non-current liabilities
Long-term bank loan	115.67%1.09B	-58.31%288.29M	-23.39%507.08M	-78.01%691.53M	-78.46%661.91M	1,556.56%3.15B	----	4.14%3.07B	----	-93.46%189.85M
Financial lease liabilities-non-current liabilities	--12.16M	--1.17M	----	----	----	----	----	----	----	----
Deferred income-non-current liabilities	-0.46%184.55M	-0.18%187.15M	-2.53%185.39M	36.13%187.49M	36.21%190.21M	29.27%137.73M	----	35.92%139.65M	----	42.18%106.54M
Total non-current liabilities	86.34%1.29B	-45.78%476.6M	-18.73%692.48M	-73.22%879.02M	-73.47%852.12M	1,007.56%3.28B	----	5.21%3.21B	----	-90.05%296.4M
Total liabilities	-39.71%3.83B	-17.37%4.81B	31.60%6.35B	28.73%5.82B	11.78%4.83B	1.42%4.52B	----	-21.31%4.32B	----	-15.72%4.46B
Total assets less total liabilities	22.15%8.67B	30.73%7.94B	18.46%7.09B	0.82%6.07B	30.27%5.99B	17.97%6.02B	----	-7.58%4.6B	----	10.39%5.1B
Total equity and non-current liabilities	27.86%9.96B	21.05%8.41B	13.83%7.79B	-25.31%6.95B	-12.40%6.84B	72.29%9.3B	----	-2.72%7.81B	----	-28.95%5.4B
Equity
Share capital	0.00%879.97M	0.00%879.97M	0.00%879.97M	0.00%879.97M	0.00%879.97M	0.00%879.97M	----	0.00%879.97M	----	96.06%879.97M
Reserve	29.02%7.79B	40.97%7.06B	23.26%6.03B	1.55%5B	39.71%4.9B	22.87%4.93B	----	-9.69%3.5B	----	-2.21%4.01B
Shareholders' Equity	25.32%8.67B	34.85%7.94B	19.72%6.91B	1.32%5.88B	31.74%5.78B	18.75%5.81B	----	-7.90%4.38B	----	10.95%4.89B
Non-controlling interest	----	----	-15.63%179.55M	-12.88%185.12M	0.10%212.82M	-0.04%212.48M	----	-0.57%212.61M	----	-0.95%212.56M
Total equity	22.15%8.67B	30.73%7.94B	18.46%7.09B	0.82%6.07B	30.27%5.99B	17.97%6.02B	----	-7.58%4.6B	----	10.39%5.1B
Total equity and total liabilities	-7.07%12.49B	7.19%12.74B	24.33%13.44B	12.79%11.89B	21.32%10.81B	10.25%10.54B	--10.07B	-14.78%8.91B	--8.91B	-3.54%9.56B
Currency Unit	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY
Accounting Standards	IAS	IAS	IAS	IAS	IAS	IAS	CAS (2007)	IAS	CAS (2007)	IAS
Audit Opinions	--	Unqualified Opinion	--	Unqualified Opinion	--	Unqualified Opinion	--	--	--	Unqualified Opinion
Auditor	--	KPMG Huazhen Certified Public Accountants (Special General Partnership)	--	KPMG Huazhen Certified Public Accountants (Special General Partnership)	--	KPMG Huazhen Certified Public Accountants (Special General Partnership)	--	--	--	KPMG Huazhen Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data

01558 HEC CJ PHARM

HEC CJ PHARM Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Analysis

Analyst Rating

Price Target